Conferences and event

10 Medical Affairs Conferences in Late 2020 and Early 2021

The coronavirus pandemic has thrust pharmaceutical companies into the spotlight. As a result, medical affairs professionals are more visible and important than ever. Creating and disseminating accurate information is essential. So is staying abreast of the latest and developments and trends.


Conferences and events offer the perfect opportunity for medical affairs professionals to learn and network. While many have been disrupted by the pandemic, plenty have been rescheduled or moved online.

Here are the major medical affairs conferences still going ahead in late 2020 and early 2021.

Medical Affairs Strategic Summit

Available on-demand

The 2020 edition of the Medical Affairs Strategic Summit was a completely virtual event that can now be accessed for free at any time by professionals in the pharmaceutical, biotech and medical device industries.

The event covers the following five focus areas:

  • Launch readiness.
  • Medical affairs strategy.
  • Medical operations and technology.
  • MSL and field strategy.
  • Investigator-initiated trials.

Each day includes several panel discussions and at least one keynote speech. MA teams will discover the impact of innovative technologies like AI on their operations, how to streamline efficiencies and engage with KOLs, the data mining activities that can improve customer engagement, and how to improve internal approval processes.

Speakers include:

  • Ashish Dugar, Ph.D., MBA, vice president of global medical affairs, Sarepta Therapeutics
  • Reina Benabou, M.D., Ph.D., senior vice president and chief medical officer, Cognivue, Inc.
  • Peter Shaw, MBBS, DRCOG, vice president, medical affairs and chief medical officer, Bioventus

Pharmaceutical Regulatory Affairs and IPR Conference

Oct. 16-17, 2020

The ninth International Conference on Pharmaceutical Regulatory Affairs and IPR, previously scheduled to be held in Munich, Germany, will now be hosted via webinar.

The conference brings together professionals, executives and academics from the pharma, clinical and healthcare industries to discuss best practices on preclinical research and medical and regulatory affairs.

The two-day event will be a mix of keynote speeches, panel discussions, workshops and networking opportunities.

Speakers are to be announced.

MedComm 3.0

Oct. 19-20, 2020

The third annual MedComm 3.0 EAST conference is bringing together the best and brightest professionals from the industry to explore and discuss the communication challenges facing the pharmaceutical industry.

Attendees will be able to learn directly from C-level executives who have implemented advanced strategies for preserving and improving company reputation, network with their peers and create a roadmap to achieve personal success in the industry.

Speakers to be announced.


Medical Affairs Leadership Forum

Oct. 19-20, 2020

Medical affairs professionals can be overlooked and underappreciated. That’s why the Medical Affairs Leadership Forum isn’t so much about understanding the latest strategies as it is about improving the professional and personal development of individuals working in the industry.

The forum focuses on helping medical affairs professionals to improve their job satisfaction, reduce burnout and achieve a better work-life balance. Attendees will leave feeling valued and inspired, ready to give their best to their company going forward.

Speakers include:

  • Eddie Power, Ph.D., vice president of North America medical affairs, hospital business, Pfizer.
  • Renu Juneja, Ph.D., head of scientific evidence and communications, oncology US medical affairs, Janssen.
  • Tracy Bunting, Ph.D., director of global medical affairs, Pfizer Oncology Publications.

Medical Affairs in Rare Diseases Forum

Nov. 5-6, 2020

The third annual Medical Affairs in Rare Diseases Forum is a two-day online live stream designed to help medical affairs professionals discover new strategies, improve their programs and work more closely with the patient community.

Specifically, attendees will learn the advanced strategies medical affairs teams are using to achieve success with rare diseases, how to improve their department’s ability to understand patient needs and how the regulatory pathway works with regard to orphan drugs.

Speakers include:

  • Isabel Firmino, Ph.D., vice president, head of global medical affairs therapeutic areas, Alexion Pharmaceuticals.
  • Ana Bozas, Ph.D., CMPP, associate director of medical communications, Akcea Therapeutics.
  • Derek Ansel, M.S., CCRA, director of strategic development, rare, orphan, and pediatric diseases, Synteract.

20th Medicinal & Pharmaceutical Sciences Congress

Nov. 9-10, 2020

The Med Pharma Congress 2020 is an international platform that provides an opportunity for pharmaceutical professionals, marketers, researchers, academics and other healthcare professionals to discuss and explore the latest advances and challenges across pharmaceutical science.

The theme of this year’s congress is: “Challenges and new ideas in pharmaceutical and medicinal sciences.” The event promises 15 expert-led tracks that cover the breadth of the industry. MA teams will be particularly interested in Track 5, which covers pharmacovigilance.

Speakers to be announced.


Nov. 9-11, 2020

MAPS is the world leader in connecting the medical affairs industry. Their 2020 EMEA conference promises to deliver a value-packed, interactive and memorable experience to the medical affairs community in Europe, the Middle East and Asia.

The virtual event is spread over three days to allow attendees to participate as much as possible without major disruptions to daily work schedules. Participants have a choice of two core events on Monday and Wednesday, with Tuesday slated to offer country-level discussion groups and career-focused talks.

Speakers include:

  • Damian Largier, vice president of medical affairs, international developed markets, Pfizer.
  • Faisal Mehmud, MBBS, vice president, global head safety risk management, Bristol Myers Squibb.
  • Danie du Plessis, M.D., executive vice president of medical affairs, Kyowa Kirin.


Medical Affairs Congress

Dec. 1-3, 2020

The 2020 Medical Affairs Congress offers a 360-degree view of the medical affairs landscape to industry professionals that encompasses the latest findings from investigator-initiated sponsored research, expanded access programs and medical publications.

Attendees will learn advanced strategies in medical science communications, how to engage with KOLs compliantly, how to conduct effective investigator studies and how to promote excellence throughout the MA team.

As a completely virtual event, attendees will benefit from on-demand access to topics, a customizable agenda, convenient session scheduling and more direct access to thought leaders.

Speakers include:

  • Peter Pitts, president at the Center for Medicine in the Public Interest.
  • Elizabeth Faust, Ph.D., executive vice president of medical affairs at Tricida.
  • Scott McConnell, Pharm.D., vice president of medical affairs at Chiasma.

Pharmacovigilance USA 2021

Feb. 25-26, 2021

Pharmacovigilance USA 2021 is the country’s leading pharmacovigilance conference and exhibition. The event brings together executives, thought leaders and regulators to discuss their learnings and experiences with other like-minded professionals.

Held over two days, the conference will explore the latest developments in legislation, operational challenges, risk management and technology. The following key themes will be discussed:

  • The impact of PV legislation changes.
  • How to assure compliance.
  • PV audits and inspections.
  • Risk management plans.
  • Increasing transparency.
  • The harmonization of the regulatory framework.

Speakers to be announced.

Pharma Europe 2021

March 16-18, 2021

Pharma Europe 2021 (formerly EyeForPharma Barcelona) brings together the pharmaceutical industry’s innovators and decision-makers from around the world. It is the largest and most senior event in Europe — over 80% of the 2000+ attendees are expected to be director level and above.

Attendees will be able to choose from six stages of carefully curated discussions led by leaders from across the pharmaceutical value-chain, including commercial, marketing, patient engagement and medical affairs.

Speakers to be announced.

Images by: Andriy Popov/©123RF Stock Photo, humberto chavez, dolgachov/©123RF Stock Photo

Want to stay up to date with our news?

To top